Clinical Trials Browser

Interventional × Injections, Subcutaneous × 30 days × Clear all

NCT07603479 2026-05-22

A Phase I Study of JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Phase 1 Not yet recruiting

Lymphoma, Non-Hodgkin, Neoplasms